Cook Medical: APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease Announces Completion of Patient Enrollment

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Completion of target patient enrollment and six-month follow-up data in phase II of the APPRAISAL clinical trial was announced today. The trial, currently being held in Germany, was designed to study the effect of Resten-MP in the prevention of cardiovascular restenosis when used in conjunction with the placement of one or more bare metal stents.

Back to news